Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Barbas

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Journal of Virology|September 1, 1997
Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. offH Mo, L Stamatatos, J E Ip, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 1992
Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivityC F Barbas, J E Crowe, D Cababa, et al.
Journal of Virology|December 1, 1996
In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelopeP W Parren, P Fisicaro, A F Labrijn, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2001
Synthesis of an organoinsulin molecule that can be activated by antibody catalysisD S Worrall, J E McDunn, B List, et al.
Journal of Virology|June 20, 2001
Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12M B Zwick, L L Bonnycastle, A Menendez, et al.
The Journal of Biological Chemistry|May 2, 2000
The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodiesC Rader, G Ritter, S Nathan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1992
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitroC F Barbas, E Björling, F Chiodi, et al.
Journal of Virology|January 1, 1995
Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120J P Moore, Y Cao, L Qing, et al.
Science (New York, N.Y.)|February 12, 1998
Immune versus natural selection: antibody aldolases with enzymic rates but broader scopeC F Barbas, A Heine, G Zhong, et al.
Virology|January 8, 1999
Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoproteinJ E Crowe, C Y Firestone, R Crim, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Journal of Virology|September 1, 1997
Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. offH Mo, L Stamatatos, J E Ip, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 1992
Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivityC F Barbas, J E Crowe, D Cababa, et al.
Journal of Virology|December 1, 1996
In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelopeP W Parren, P Fisicaro, A F Labrijn, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2001
Synthesis of an organoinsulin molecule that can be activated by antibody catalysisD S Worrall, J E McDunn, B List, et al.
Journal of Virology|June 20, 2001
Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12M B Zwick, L L Bonnycastle, A Menendez, et al.
The Journal of Biological Chemistry|May 2, 2000
The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodiesC Rader, G Ritter, S Nathan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1992
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitroC F Barbas, E Björling, F Chiodi, et al.
Journal of Virology|January 1, 1995
Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120J P Moore, Y Cao, L Qing, et al.
Science (New York, N.Y.)|February 12, 1998
Immune versus natural selection: antibody aldolases with enzymic rates but broader scopeC F Barbas, A Heine, G Zhong, et al.
Virology|January 8, 1999
Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoproteinJ E Crowe, C Y Firestone, R Crim, et al.
Pageof 10